In AKI models, P-Rex1 deficiency lessens neutrophil infiltration and kidney damage, positioning E-selectin and P-Rex1 as potential therapeutic targets for mitigating AKI severity (67). The gene discussed is PREX1; the disease is acute kidney injury.